Rocket One Inc.

RKTO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Mar 2024
Revenue $1.24B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $571.6K
SG&A Expense $1.6M
Operating Income $-2.2M
Operating Margin -0.2%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-2.1M
Net Margin -0.2%
EPS (Basic) $-0.25
EPS (Diluted) $-0.25
Shares Outstanding (Basic) 8.8M
Shares Outstanding (Diluted) 8.8M
Dividends Per Share